Financial statements Alfa-Bio
Balance sheet of Alfa-Bio
Company age:
Age:
6 y. 11 m. 1 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of ALFA-BIO
|
Year
|
2019
|
2020
|
2021
|
|---|---|---|---|
| Total assets | 549 149,93 | 1 616 877,10 | 716 464,31 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 |
| B. Current assets | 549 149,93 | 1 616 877,10 | 716 464,31 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 |
| Total liabilities | 549 149,93 | 1 616 877,10 | 716 464,31 |
| A. Equity | -6 313,14 | 393 430,99 | 471 663,92 |
| B. Liabilities and provisions for liabilities | 555 463,07 | 1 223 446,11 | 244 800,39 |
| I. Long-term liabilities | - | 0,00 | 0,00 |
| II. Short-term liabilities | 555 463,07 | 1 223 446,11 | 244 800,39 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.